SR-1114 - Moligand™ , CAS No.S613690

CAS: S613690 Cat. No.: S613690 PubChem CID: 155925846
Disponibile su ordine
QUALITÀ & PUREZZA Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Storage
Room temperature
Application
PROTAC
★
Dimensione
Germania (EU)
USA*
Prezzo
Qtà
5mg
S613690-5mg
Su ordinazione · 8–12 settimane
736,62€
25mg
S613690-25mg
Su ordinazione · 8–12 settimane

1.488,09€

2.391,40€
Salva 903,32 € (37.77%)
Enter a quantity for the sizes you want to add.

Specifiche

Specifiche e purezza
Moligand™
Condizioni di conservazione di stoccaggio
Room temperature
Grado
Moligand™
Nomi e identificatori
SMILES
O=C(COc1cccc2c1C(=O)N(C2=O)C1CCC(=O)NC1=O)NCCOCCOCCNS(=O)(=O)Nc1cccc(c1)c1nc2n(c1)cc(cc2)C(=O)NC1CCC1
IUPAC Name
N-Cyclobutyl-2-(3-((N-(2-(2-(2-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)acetamido)ethoxy)ethoxy)ethyl)sulfamoyl)amino)phenyl)imidazo[1,2-a]pyridine-6-carboxamide
InChIKey
WPVVPCVQEBQVLL-UHFFFAOYSA-N
InChI
1S/C39H42N8O11S/c48-33-13-11-30(37(51)44-33)47-38(52)28-8-3-9-31(35(28)39(47)53)58-23-34(49)40-14-16-56-18-19-57-17-15-41-59(54,55)45-27-7-1-4-24(20-27)29-22-46-21-25(10-12-32(46)43-29)36(50)42-26-5-2-6-26/h1,3-4,7-10,12,20-22,26,30,41,45H,2,5-6,11,13-19,23H2,(H,40,49)(H,42,50)(H,44,48,51)
PubChem CID
155925846

Dati avanzati

Struttura 3D
Modello di struttura chimica interattiva





Certificati (CoA, COO, BSE/TSE e tabella di analisi)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
Calcolatori di soluzioni
Recensioni

Recensioni dei clienti

Application Protocols

No tested applications or protocols are provided in the Product Data for SR-1114. The following are general, non-item-specific suggestions for handling small-molecule research compounds:

  • Stock preparation: Dissolve in anhydrous DMSO to 10–50 mM. Vortex and, if needed, sonicate briefly. Filter through 0.22 μm PTFE for particle removal.
  • Working solutions: Dilute into assay buffer to the desired concentration, matching the final DMSO content across samples and controls. Typical final DMSO is 0.1–1% v/v.
  • Plate handling: Use low-binding plates/tubes for hydrophobic compounds. Seal plates to minimize evaporation; equilibrate to room temperature before measurement to reduce edge effects.
  • Stability checks: Assess short-term stability (hours to days) by LC–MS in your assay matrix. Prepare fresh dilutions daily unless stability is demonstrated.

These instructions are general. For any validated, product-specific protocols (e.g., enzyme assay conditions, positive controls), please refer to Aladdin’s detailed datasheet if available or contact technical support with your application details.

Biological Roles

Item-specific biological function, mechanism, and targets for SR-1114 are not provided in the Product Data. Therefore, no claims are made regarding biochemical role, pathway modulation, or cellular activity.

General note for users evaluating small-molecule research compounds:

  • Treat SR-1114 as a putative probe candidate pending validation. Establish potency, selectivity, and mechanism of action using orthogonal assays to distinguish specific binding from non-specific effects (e.g., aggregation, redox cycling, covalent reactivity).
  • Verify chemical stability in the intended assay matrix (buffer composition, pH, ionic strength) and over the intended exposure time. Monitor by LC–MS for degradation or adduct formation.
  • Assess interference liabilities: intrinsic fluorescence/absorbance (inner-filter effects), metal chelation, surfactant sensitivity, and reactivity with assay reporters (e.g., DTT, H2O2-coupled systems).
  • Employ counterscreens (e.g., detergent robustness, redox assays, target-unrelated proteins) to evaluate PAINS-like behaviors. Literature alerts should be cross-checked with the exact structure from the CoA.

Research Use Note: For research use only. No biological or clinical claims are made. Any biological role described in external databases for PubChem CID 155925846 should be independently verified using the specific lot documentation from Aladdin Scientific.

Buffer Applications

SR-1114 is not a buffering agent and no buffer-system parameters (pKa, buffering range) are provided. As such, it is not typically used to establish pH control.

Practical guidance when adding small molecules to buffers (general):

  • Prepare a concentrated DMSO stock and perform stepwise dilution into the assay buffer to avoid local supersaturation and precipitation. Keep final DMSO at 0.1–1% v/v when possible.
  • Common biochemical buffers: HEPES (pKa ~7.5, pH 6.8–8.2), PBS (phosphate; multiple pKas), Tris (pKa ~8.1, pH 7–9). Select based on target protein stability and avoid buffers that can coordinate metals or react with electrophilic motifs if relevant.
  • Include non-ionic surfactants (e.g., 0.01–0.05% Tween 20 or Triton X-100) to mitigate aggregation artifacts where appropriate.
  • Filter buffers (0.22 μm) and degas for sensitive biophysical measurements (SPR, ITC).

If SR-1114 exhibits limited aqueous solubility, consider pH adjustment only if its ionizable groups are known from the CoA; otherwise, avoid unverified pH manipulations that may induce degradation.

Green Alternatives

Given the lack of structure-specific constraints, solvent choices and handling practices offer the main leverage for greener operation.

Greener solvent selection (general guidance):

  • Prefer water and aqueous buffers as the primary medium; limit DMSO to the minimum required for solubility.
  • Where organic is needed, consider ethanol or isopropanol over acetonitrile/DMF when assay tolerance and solubility allow.
  • For synthetic handling (if applicable), consider 2-MeTHF or CPME as alternatives to THF/ether and ethyl acetate over dichloromethane, recognizing performance tradeoffs.

Illustrative comparison (literature-based, general):

  • Water/buffer: safest, lowest environmental impact; limited solubility for hydrophobic compounds.
  • Ethanol: bio-based option; protic effects on biomolecules must be evaluated.
  • Acetonitrile: excellent for LC; less preferred environmentally; use sparingly and recycle when possible.
  • DMF/DMSO: effective solubilizers; assess EHS profile and ensure appropriate waste segregation.

Operational practices:

  • Use micro-aliquots to reduce freeze–thaw cycling and waste.
  • Implement solvent recovery for acetonitrile in analytical labs.
  • Minimize single-use plastics by adopting solvent-compatible glassware and plate seals.

All recommendations are general; confirm compatibility with SR-1114 once structural and solubility details are available from the CoA/SDS.

Pharmaceutical Uses

No pharmacopeial status, excipient role, or manufacturing use is specified for SR-1114 in the Product Data. It is supplied for research use only and is not intended for human or veterinary use.

General considerations for discovery-phase compounds (non-clinical):

  • Pre-formulation screening: Determine solubility, stability, and polymorphic form (if solid) to inform in vitro dosing and storage conditions.
  • Interference assessment: Evaluate potential for assay interference due to color/fluorescence or surfactant sensitivity before translating to formulation-like vehicles.
  • Salt screening (if relevant): If ionizable, formation of stable salts can improve solubility and handling; any such modifications should be clearly distinguished from the parent in records.

If downstream development is contemplated, obtain comprehensive CMC data (identity, purity, residual solvents, elemental impurities) directly from the CoA/SDS and perform independent verification under your QA systems. Aladdin Scientific does not provide clinical-use authorization for this SKU.

Physical Properties

Item-specific property data

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting/Boiling Point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • logP, pKa, refractive index, UV cutoff: Not specified for this item; refer to CoA/Spec Sheet.

Practical guidance (general, not item-specific)

  • Solubility screening: For library-type small molecules, begin with DMSO at 10–50 mM, then evaluate aqueous compatibility by dilution into buffer (final DMSO 0.1–1% v/v). If precipitation occurs, consider co-solvents (0.5–5% v/v acetonitrile, ethanol, or DMF) and warm to 25–37 C with brief sonication.
  • Hygroscopicity/photosensitivity: Unknown for this item; store in original container and minimize light/air exposure until specifics are confirmed from CoA/SDS.
  • Solid vs. oil: Unspecified. If received as a solid, gently grind clumps before weighing; if as an oil, use density-independent volumetric addition from a standardized DMSO stock solution.

Analytical confirmation (general suggestions)

  • Identity/purity verification can be done via LC–MS (single ion extraction tied to literature [M+H]+ if available), 1H NMR in DMSO-d6 or CDCl3, and HPLC/UPLC method scouting across 5–95% MeCN/H2O (+0.1% formic acid).

Always defer to the item’s CoA and SDS for authoritative physical property data.

Quality and Grades

Item-specific quality designation

  • Grade/Purity: Moligand™ (as provided). Numerical purity, residual solvent content, metal limits, and chromatographic specifications: Not specified for this item; refer to CoA/Spec Sheet.

What Moligand™ implies (general explanation)

  • Moligand™ indicates a small-molecule ligand/probe orientation suitable for screening and discovery workflows. Typical expectations for such grade include:
    • Consistency for HTS/fragment or lead-like screening, enabling reliable assay performance.
    • Documentation: Availability of identity confirmation (e.g., LC–MS and/or NMR) per lot.
    • Packaging that supports DMSO stock preparation and plate-based distribution.

Analytical considerations

  • For spectroscopy- or chromatography-sensitive applications (e.g., high-sensitivity biophysical assays), verify lot-specific UV background, fluorescence interference, and purity by LC–UV/MS using the diluent and gradient intended for screening.

Stabilizers and additives

  • Stabilizers or salt form: Not specified for this item; refer to CoA/Spec Sheet. If salt form is relevant to solubility/assay pH, confirm before preparing stocks.

If your application requires enhanced grade (HPLC grade solvents, low-peroxide status, elemental impurities, or photostability verification), request the extended QC dossier or a targeted CoA addendum for this SKU.

Reaction and Applications

This SKU is positioned as a small-molecule/ligand-type research compound rather than a commodity reagent. Without structural disclosure, specific reaction chemistry cannot be recommended for SR-1114 itself. Nevertheless, typical applications for compounds in small-molecule libraries include:

  • Assay tool deployment: Preparation of DMSO stocks for use in biochemical/biophysical screens (enzymatic assays, binding assays, thermal shift/DSF, nanoDSF, MST, SPR), and in vitro cell-free systems. Keep final DMSO low to minimize solvent effects.
  • Orthogonal confirmation: Applying multiple readouts (e.g., LC–MS-based target engagement, thermal profiling) to mitigate assay interference from promiscuous aggregators or redox-active species.
  • Analytical method development: LC–MS/UPLC method scouting to ensure clean, single-component behavior under screening diluents.

If SR-1114 is to be used as a synthetic substrate/intermediate, first obtain the full structure from the CoA or PubChem CID 155925846 and confirm reactivity domains (e.g., electrophiles/nucleophiles, aromatic heterocycles) before selecting conditions. In absence of item-specific functional group data, avoid prescriptive named-reaction guidance to prevent misuse.

For high-throughput screening campaigns, plan plate maps to monitor edge effects, include vehicle controls, and confirm compound integrity over the assay window (on-deck stability at ambient conditions).

Reaction Conditions

No structure-specific reaction conditions are available for SR-1114 from the Product Data. As such, prescriptive conditions (solvent, catalysts, temperatures, and expected yields) cannot be provided without risking mismatch to the actual functional groups present.

General guidance if derivatization is planned after confirming structure from the CoA:

  • Mild couplings: Employ amide couplings (HATU/DIPEA, EDCI/NHS) in DMF or DCM alternatives like EtOAc when compatible; 0–25 C to preserve sensitive motifs.
  • Cross-couplings: Suzuki–Miyaura under Pd catalysis in aqueous-organic media (2-MeTHF/H2O or dioxane/H2O) with K2CO3 or Cs2CO3; 50–90 C depending on substrate.
  • Heteroatom alkylations: Selective N- or O-alkylations using carbonate bases in acetonitrile or acetone; monitor for overalkylation.
  • Purification: Prefer reverse-phase preparative LC for polar/ionizable compounds and normal-phase silica for neutral scaffolds; choose greener eluents where feasible.

All values above are general literature practices and must be tailored to the confirmed structure of SR-1114 before use.

Safety and Handling

GHS/SDS information (item-specific)

  • Signal Word: Not specified for this item; refer to SDS.
  • Hazard Statements (H-codes): Not specified for this item; refer to SDS.
  • Pictograms and Classification: Not specified for this item; refer to SDS.

General laboratory precautions (for small-molecule research compounds)

  • Use in a chemical fume hood. Avoid inhalation of dust/vapors and contact with skin/eyes.
  • PPE: Lab coat, safety glasses, and appropriate chemically resistant gloves (e.g., nitrile). Consider double-gloving for extended handling of DMSO solutions.
  • Avoid incompatible materials until specifics are known; in general keep away from strong oxidizers, strong acids/bases, and ignition sources.

First aid (general guidance; consult SDS for specifics)

  • Skin/eye contact: Rinse with water for at least 15 minutes and remove contaminated clothing. Seek medical attention if irritation persists.
  • Inhalation: Move to fresh air; seek medical attention if symptoms occur.
  • Ingestion: Rinse mouth; do not induce vomiting unless directed by medical personnel.

Spill and disposal

  • Small spills: Absorb with inert material, collect in chemical waste. Prevent release to drains.
  • Waste: Dispose via licensed chemical waste contractor; follow institutional and local regulations.

Because item-specific hazards are not provided here, handle as a potentially harmful organic compound and consult the product SDS prior to use. Research use only.

Solvent Selection

With no disclosed structure, choose solvents empirically following standard practices for small-molecule screening compounds.

  • Primary stock solvent: DMSO (anhydrous) is the default for 10–50 mM stocks; filter (0.22 μm PTFE) if necessary.
  • Secondary options: DMF, acetonitrile, ethanol, methanol for analytical/sample prep; use water-miscible solvents for assay dilution.
  • Buffer compatibility: Titrate organic content to ≤1% v/v DMSO in biochemical assays when possible to limit solvent effects; for biophysical assays (e.g., SPR, DSF), maintain solvent match between sample and reference.
  • Immiscible/less preferred: Chlorinated solvents for long-term storage of assay stocks are discouraged; reserve for synthetic manipulation if required.

Comparison (general characteristics; literature-based):

  • DMSO: maximal solubilization power; high boiling point; excellent for cryostorage of aliquots.
  • Acetonitrile: low viscosity, UV-transparent; good for LC but can be harsh to some proteins.
  • Ethanol/Methanol: protic; can alter protein stability; acceptable for analytical use and limited assay contexts.
  • DMF: strong solvent; hygroscopic; consider toxicity and material compatibility.

Practical tips:

  • Pre-wet pipette tips with solvent to ensure accurate microvolumes.
  • Use graded dilution (serial 1:3–1:10) to identify the onset of precipitation.
  • Record and report final organic percentage in all assay readouts for reproducibility.
Storage and Reconstitution

Item-specific storage

  • Storage Conditions: Room temperature (as provided in the Product Data).
  • Shipped In: Not specified for this item; refer to CoA/Spec Sheet.
  • Appearance/physical state for storage considerations: Not specified for this item; refer to CoA/Spec Sheet.

General reconstitution guidance (not item-specific)

  • For solids: Bring to room temperature in a desiccator, then prepare concentrated DMSO stock (e.g., 10–50 mM). Record exact mass and final volume to enable reproducibility.
  • For oils or low-melting solids: Weigh by difference or prepare volumetrically using calibrated syringes; dissolve directly in DMSO.
  • Aliquoting: Divide stocks into single-use aliquots to minimize freeze–thaw and adventitious water uptake. Store tightly sealed, protected from light. Although room-temperature storage is indicated for the neat material, DMSO stock solutions are commonly stored refrigerated or frozen for stability; confirm with your own stability data.

Stability notes

  • Peroxides, water content, and light sensitivity: Not specified for this item; consult SDS/CoA. Protect from moisture and light as a precaution until specifics are known.

Always label aliquots with compound ID (SR-1114), concentration, solvent, and date. Research use only.

Structure and Identity

Item-specific identifiers (from Product Data)

  • Product Name: SR-1114 (SKU: S613690)
  • CAS: S613690 (internal placeholder; not a standard CAS Registry No.)
  • PubChem CID: 155925846
  • InChIKey: 404898 (truncated/atypical format as provided)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular Weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features

  • Structural description (functional groups, ring systems, stereochemistry): Not specified for this item; refer to CoA/Spec Sheet. With no disclosed SMILES or formula, a definitive 2D structural description cannot be provided here.

Contextual note (literature/informatics)

  • Given the presence of a PubChem CID (155925846), literature databases may contain a full structural record, synonyms, and computed properties. Users may consult PubChem for a literature depiction, but any external data should be confirmed against the item’s CoA/SDS from Aladdin Scientific before use in regulated workflows.

Category

  • Listed under: Small Molecules & Compound Libraries (小分子和化合物库), consistent with use as a screening/probe candidate rather than as a commodity reagent.

If you require definitive identifiers for registration or LIMS import (e.g., canonical SMILES, exact mass), please request the latest CoA/Spec Sheet for this specific lot.

Synthetic Utility

The Product Data do not disclose the structure of SR-1114; therefore, specific synthetic transformations, reactivity patterns, and named-reaction guidance cannot be reliably provided for this item.

General strategies for library compounds when derivatization is desired:

  • Confirm exact structure and functional group inventory from the CoA or trusted databases (linked to PubChem CID 155925846), then map electrophilic/nucleophilic sites, heteroatom content, and potential protecting-group needs.
  • Plan small structure–activity panels by conservative modifications (bioisosteric swaps, halogen edits, solubilizing side chains) while retaining the core scaffold.
  • Validate stability under standard operations (e.g., amide coupling, SNAr, Suzuki–Miyaura) using micro-scale trials before scale-up, as unknown liabilities (e.g., acid/base sensitivity) can cause decomposition.

Analytical control:

  • Track conversions by LC–MS; establish reference retention time and mass for the parent compound to distinguish starting material, product, and byproducts.

If SR-1114 is intended only as a screening tool, using it as-received without chemical modification is recommended unless your program specifically calls for SAR expansion with full structural disclosure and IP review.

Target Specificity

No target, epitope, enzyme class, receptor family, or binding specificity is provided for SR-1114 in the Product Data. Consequently, no claims are made regarding molecular targets, selectivity profiles, or species reactivity.

If target information is found in external literature associated with PubChem CID 155925846, treat it as provisional and validate in your laboratory using orthogonal assays (e.g., binding vs. functional activity, counterscreens against related targets, and biophysical confirmation). Ensure correspondence between the literature structure and the exact lot supplied (via CoA).

Domande frequenti

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is S613690. InChIKey WPVVPCVQEBQVLL-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

Hai bisogno di aiuto per scegliere la qualità?

La nostra guida alla selezione delle qualità copre purezza, stato dello stabilizzatore e idoneità all'applicazione per tutte le varianti del nostro catalogo.

Visualizza la guida alle qualità Moligand™ →

Desidera che le inviamo un messaggio quando avremo sconti disponibili?

Ricordamelo più tardi

Grazie! Controlli la sua casella di posta per confermare.

Ops! Le notifiche sono disabilitate.